Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Small-molecule inhibitors of the interaction between TNF and TNFR.

Davis JM, Colangelo J.

Future Med Chem. 2013 Jan;5(1):69-79. doi: 10.4155/fmc.12.192. Review.

PMID:
23256814
2.

Photochemically enhanced binding of small molecules to the tumor necrosis factor receptor-1 inhibits the binding of TNF-alpha.

Carter PH, Scherle PA, Muckelbauer JK, Voss ME, Liu RQ, Thompson LA, Tebben AJ, Solomon KA, Lo YC, Li Z, Strzemienski P, Yang G, Falahatpisheh N, Xu M, Wu Z, Farrow NA, Ramnarayan K, Wang J, Rideout D, Yalamoori V, Domaille P, Underwood DJ, Trzaskos JM, Friedman SM, Newton RC, Decicco CP.

Proc Natl Acad Sci U S A. 2001 Oct 9;98(21):11879-84. Erratum in: Proc Natl Acad Sci U S A 2001 Dec 18;98(26):15393. Muckelbauer JA [corrected to Muckelbauer JK].

3.

Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin.

Mancini F, Toro CM, Mabilia M, Giannangeli M, Pinza M, Milanese C.

Biochem Pharmacol. 1999 Sep 1;58(5):851-9.

PMID:
10449196
4.

TNF alpha and the TNF receptor superfamily: structure-function relationship(s).

Idriss HT, Naismith JH.

Microsc Res Tech. 2000 Aug 1;50(3):184-95. Review.

PMID:
10891884
6.

The use of TNF family ligands and receptors and agents which modify their interaction as therapeutic agents.

Gardnerova M, Blanqué R, Gardner CR.

Curr Drug Targets. 2000 Dec;1(4):327-64. Review.

PMID:
11467075
7.

Development of a novel TNF alpha ligand-receptor binding assay for screening NATCHEM Libraries.

MacAllan D, Sohal J, Walker C, Hill D, Moore M.

J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):521-9.

PMID:
9029512
8.
9.
10.

Three TNFR-binding domains of PGRN act independently in inhibition of TNF-alpha binding and activity.

Tian Q, Zhao Y, Mundra JJ, Gonzalez-Gugel E, Jian J, Uddin SM, Liu C.

Front Biosci (Landmark Ed). 2014 Jun 1;19:1176-85.

11.

TNF-alpha as a therapeutic target in inflammatory diseases, ischemia-reperfusion injury and trauma.

Esposito E, Cuzzocrea S.

Curr Med Chem. 2009;16(24):3152-67. Review.

PMID:
19689289
12.

A novel human scFv fragment against TNF-alpha from de novo design method.

Chang H, Qin W, Li Y, Zhang J, Lin Z, Lv M, Sun Y, Feng J, Shen B.

Mol Immunol. 2007 Jul;44(15):3789-96. Epub 2007 May 7.

PMID:
17485112
13.
14.

Tumor necrosis factor family ligand-receptor binding.

Zhang G.

Curr Opin Struct Biol. 2004 Apr;14(2):154-60. Review.

PMID:
15093829
15.

Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor.

Takasaki W, Kajino Y, Kajino K, Murali R, Greene MI.

Nat Biotechnol. 1997 Nov;15(12):1266-70.

PMID:
9359109
16.

Tumor necrosis factor induces lipopolysaccharide tolerance in a human adenocarcinoma cell line mainly through the TNF p55 receptor.

Laegreid A, Thommesen L, Jahr TG, Sundan A, Espevik T.

J Biol Chem. 1995 Oct 27;270(43):25418-25.

17.

TNF-R1 signaling: a beautiful pathway.

Chen G, Goeddel DV.

Science. 2002 May 31;296(5573):1634-5. Review.

PMID:
12040173
19.

Small Molecules as Anti-TNF Drugs.

Richmond V, Michelini FM, Bueno CA, Alché LE, Ramírez JA.

Curr Med Chem. 2015;22(25):2920-42. Review.

PMID:
26219390
20.

BAFF/BLyS receptor 3 comprises a minimal TNF receptor-like module that encodes a highly focused ligand-binding site.

Gordon NC, Pan B, Hymowitz SG, Yin J, Kelley RF, Cochran AG, Yan M, Dixit VM, Fairbrother WJ, Starovasnik MA.

Biochemistry. 2003 May 27;42(20):5977-83.

PMID:
12755599
Items per page

Supplemental Content

Write to the Help Desk